创新医疗：2025年前三季度净利润约472万元

Group 1 - The core viewpoint of the article highlights the financial performance of Innovation Medical in Q3 2025, showing a revenue decline but a significant increase in net profit and earnings per share [1] Group 2 - For the first three quarters of 2025, Innovation Medical reported revenue of approximately 597 million yuan, a year-on-year decrease of 2.11% [1] - The net profit attributable to shareholders was approximately 4.72 million yuan, reflecting a year-on-year increase of 116.97% [1] - The basic earnings per share stood at 0.01 yuan, which is an increase of 116.67% year-on-year [1] Group 3 - As of the report date, the market capitalization of Innovation Medical is 10.3 billion yuan [2] - The article also discusses the broader context of the Chinese innovative drug market, noting that overseas licensing has generated 80 billion US dollars this year [2] - There is a contrast presented between the hot secondary market for biomedicine and the cooling fundraising environment in the primary market [2]